Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease

NCT02388971 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study has withdrawn.

Conditions

Atherosclerotic Cardiovascular Disease

Interventions

DRUG: MLN1202
DRUG: Placebo

Sponsor

Takeda